Trust Company of Vermont’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.7K Sell
973
-1,660
-63% -$138K ﹤0.01% 476
2025
Q1
$214K Sell
2,633
-50
-2% -$4.06K 0.01% 332
2024
Q4
$242K Sell
2,683
-375
-12% -$33.8K 0.01% 320
2024
Q3
$302K Buy
3,058
+138
+5% +$13.6K 0.02% 288
2024
Q2
$271K Hold
2,920
0.01% 284
2024
Q1
$277K Buy
2,920
+875
+43% +$83K 0.02% 277
2023
Q4
$183K Sell
2,045
-1,065
-34% -$95.1K 0.01% 288
2023
Q3
$227K Sell
3,110
-233
-7% -$17K 0.02% 285
2023
Q2
$278K Sell
3,343
-530
-14% -$44.1K 0.02% 277
2023
Q1
$295K Sell
3,873
-60
-2% -$4.57K 0.02% 270
2022
Q4
$326K Sell
3,933
-936
-19% -$77.7K 0.02% 251
2022
Q3
$386K Sell
4,869
-407
-8% -$32.3K 0.03% 231
2022
Q2
$392K Sell
5,276
-786
-13% -$58.4K 0.03% 234
2022
Q1
$545K Hold
6,062
0.04% 217
2021
Q4
$679K Hold
6,062
0.04% 203
2021
Q3
$762K Sell
6,062
-65
-1% -$8.17K 0.05% 184
2021
Q2
$830K Buy
6,127
+9
+0.1% +$1.22K 0.06% 180
2021
Q1
$830K Sell
6,118
-240
-4% -$32.6K 0.06% 174
2020
Q4
$895K Buy
6,358
+178
+3% +$25.1K 0.07% 166
2020
Q3
$689K Buy
6,180
+39
+0.6% +$4.35K 0.06% 172
2020
Q2
$687K Sell
6,141
-4,895
-44% -$548K 0.07% 172
2020
Q1
$855K Sell
11,036
-137
-1% -$10.6K 0.08% 165
2019
Q4
$1.06M Buy
11,173
+304
+3% +$28.9K 0.08% 166
2019
Q3
$829K Buy
10,869
+4,059
+60% +$310K 0.07% 188
2019
Q2
$597K Buy
6,810
+856
+14% +$75K 0.05% 208
2019
Q1
$539K Buy
5,954
+3,421
+135% +$310K 0.05% 209
2018
Q4
$182K Buy
2,533
+255
+11% +$18.3K 0.02% 308
2018
Q3
$218K Buy
2,278
+850
+60% +$81.3K 0.02% 308
2018
Q2
$136K Buy
+1,428
New +$136K 0.01% 380
2016
Q1
Sell
-245
Closed -$17K 786
2015
Q4
$17K Buy
245
+50
+26% +$3.47K ﹤0.01% 562
2015
Q3
$12K Buy
+195
New +$12K ﹤0.01% 610